Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conjugate DNAzymes.

Takanori Kubo1, Kengo Takamori, Rumiana Bakalova

  • 1Department of Biological and Environmental Chemistry, Kyushu School of Engineering, Kinki University, 11-6 Kayanomori, Iizuka, Fukuoka 820-8555, Japan.

Nucleic Acids Research. Supplement (2001)
|September 27, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent COPA mutation drives R-spondin-independent Wnt activation in intestinal tumors.

Nature genetics·2026
Same author

Anticancer activity of Pseudomonas fluorescens lectin (PFL) targeting high-mannose glycans on breast cancer cells.

Biochimica et biophysica acta. General subjects·2026
Same author

Targeted Sensitization of Leukemic T-cells to Anticancer Drugs by SIRT1 Agonist SRT-1720.

Anticancer research·2026
Same author

Arthroscopic Anatomical Glenoid Reconstruction Using Iliac Crest Autograft With Double End-Button Fixation Technique.

Arthroscopy techniques·2026
Same author

ATP13A2 is involved in intracellular polyamine transport in lung epithelial cells.

FEBS open bio·2025
Same author

Ongoing shift toward earlier RSV season in children: the case of Saitama after COVID-19 pandemic.

Japanese journal of infectious diseases·2025
Same journal

Analysis of mammalian gene function using small interfering RNAs.

Nucleic acids research. Supplement (2001)·2003
Same journal

Identification of functional genes by libraries of ribozymes and siRNAs.

Nucleic acids research. Supplement (2001)·2003
Same journal

Two components model for the biological clock and its evaluation by computer.

Nucleic acids research. Supplement (2001)·2003
Same journal

Microinjection of magnetic micro-beads instead of endosymbiotic chlorella into Paramecium bursaria and their behavior.

Nucleic acids research. Supplement (2001)·2003
Same journal

Mutations induced by 2-hydroxy-dATP during in vitro replication with a HeLa extract.

Nucleic acids research. Supplement (2001)·2003
Same journal

Evaluating the immune responses stimulated by CpG oligodeoxynucleotides.

Nucleic acids research. Supplement (2001)·2003
See all related articles

New conjugate DNAzymes show improved RNA binding and stability, offering potential for treating leukemia by inhibiting BCR-ABL tyrosine kinase in cellular and in vivo systems.

Area of Science:

  • Biochemistry and Molecular Biology
  • Synthetic Biology
  • Biotechnology

Background:

  • DNAzymes are catalytic DNA molecules with potential therapeutic applications.
  • Modifications to DNAzymes are being explored to enhance their stability and efficacy.
  • BCR-ABL tyrosine kinase is a key target in chronic myeloid leukemia (CML).

Purpose of the Study:

  • To synthesize and characterize conjugate DNAzymes.
  • To evaluate their biochemical and cellular properties.
  • To assess their potential for inhibiting BCR-ABL tyrosine kinase.

Main Methods:

  • Solid-phase fragment condensation for DNAzyme synthesis.
  • Characterization of binding affinity to target RNA.
  • Assessment of DNase I digestion stability.

Related Experiment Videos

  • Evaluation of RNA cleaving activity.
  • Inhibition assays in a human leukemia cell line.

    • Main Results:

    • Conjugate DNAzymes exhibited increased affinity for target RNA.
    • Enhanced stability against DNase I digestion was observed.
    • RNA cleaving activity was comparable or superior to native and phosphorothioate DNAzymes.
    • Conjugate DNAzymes successfully inhibited BCR-ABL tyrosine kinase in cellular lysis.

    Conclusions:

    • Conjugate DNAzymes possess superior biochemical and stability properties.
    • These modified DNAzymes demonstrate therapeutic potential in cellular systems.
    • Conjugate DNAzymes are promising candidates for in vivo applications, including leukemia treatment.